80
Participants
Start Date
October 1, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
February 28, 2026
Early Discontinuation of Antibiotics
Antibacterial treatment (i.e piperacillin/tazobactam, ceftazidime, cefepime, meropenem, vancomycin, amikacin, tobramycin, ciprofloxacin) will be stopped after 72 hours of treatment and defervescence for 24 hours, irrespective of neutrophil count
Standard of Care
Antibacterial treatment (i.e piperacillin/tazobactam, ceftazidime, cefepime, meropenem, vancomycin, amikacin, tobramycin, ciprofloxacin) will be continued until resolution of neutropenia
RECRUITING
Alberta Health Services, Edmonton
RECRUITING
London Health Sciences Centre, London
RECRUITING
University Health Network, Toronto
RECRUITING
Vancouver General Hospital, Vancouver
University Health Network, Toronto
OTHER